Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis

被引：6

作者：

Nicolai, R. ^{[1
]}

Cortis, E. ^{[4
]}

Rava, L. ^{[3
]}

Bracaglia, C. ^{[1
]}

Pardeo, M. ^{[1
]}

Insalaco, A. ^{[1
]}

Buonuomo, P. S. ^{[2
]}

Tozzi, A. E. ^{[3
]}

De Benedetti, F. ^{[1
]}

机构：

[1] Bambino Gesu Pediat Hosp, Dept Pediat Med, IRCCS, Div Rheumatol, Piazza St Onofrio 4, I-00165 Rome, Italy

[2] Bambino Gesu Pediat Hosp, Dept Pediat Med, Ist Ricovero & Cura Carattere Sci, Div Rare Dis, Rome, Italy

[3] Bambino Gesu Pediat Hosp, Div Epidemiol, Ist Ricovero & Cura Carattere Sci, Rome, Italy

[4] Osped Santa Maria Stella, Div Pediat, Orvieto, Italy

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2016年 / 5卷 / 01期

关键词：

etanercept; herpes simplex virus; juvenile idiopathic arthritis; varicella zoster virus; RHEUMATOID-ARTHRITIS; SAFETY; EFFICACY; REGISTRY; CHILDREN; THERAPY;

D O I：

10.1093/jpids/piu078

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Incidence rates for varicella and herpes zoster were similar in patients with juvenile idiopathic arthritis receiving etanercept/methotrexate (n = 85, 184.9 patient-years [PY]) or methotrexate alone (n = 71, 199.4 PY); no complicated varicella or herpes zoster cases were reported; herpes labialis incidence was higher in patients receiving etanercept/methotrexate versus methotrexate alone (0.38 vs 0.24 PY).

引用

页码：76 / 79

页数：4

共 50 条

[21] Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study
Dallocchio, Aymeric
Canioni, Daniele
Ruemmele, Frank
Duquesne, Agnes
Scoazec, Jean-Yves
Bouvier, Raymonde
Paraf, Francois
Languepin, Jeanne
Wouters, Carine H.
Guillot, Marcel
Quartier, Pierre
Bader-Meunier, Brigitte
RHEUMATOLOGY, 2010, 49 (09) : 1694 - 1698
[22] The "head-to-head" comparison of etanercept and infliximab in treating children with juvenile idiopathic arthritis
Lamot, L.
Bukovac, L. T.
Vidovic, M.
Frleta, M.
Harjacek, M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 131 - 139
[23] Anaphylaxis to Etanercept in Two Children With Juvenile Idiopathic Arthritis
Crayne, Courtney B.
Gerhold, Kerstin
Cron, Randy Q.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (03) : 129 - 131
[24] An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register
Prince, Femke H. M.
de Bekker-Grob, Esther W.
Twilt, Marinka
van Rossum, Marion A. J.
Hoppenreijs, Esther P. A. H.
ten Cate, Rebecca
Koopman-Keemink, Yvonne
Gorter, Simone L.
Raat, Hein
van Suijlekom-Smit, Lisette W. A.
RHEUMATOLOGY, 2011, 50 (06) : 1131 - 1136
[25] Tocilizumab for the Treatment of Juvenile Idiopathic Arthritis
Decelle, Kendra
Horton, Evan R.
ANNALS OF PHARMACOTHERAPY, 2012, 46 (06) : 822 - 829
[26] Safety of biologic therapies for the treatment of juvenile idiopathic arthritis
Horneff, Gerd
EXPERT OPINION ON DRUG SAFETY, 2015, 14 (07) : 1111 - 1126
[27] Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance
Mori, Masaaki
Sugiyama, Naonobu
Morishima, Yosuke
Sugiyama, Noriko
Kokubo, Takeshi
Takei, Syuji
Yokota, Shumpei
MODERN RHEUMATOLOGY, 2018, 28 (01) : 101 - 107
[28] Discontinuation of Etanercept After Successful Treatment in Patients with Juvenile Idiopathic Arthritis
Remesal, Agustin
De Inocencio, Jaime
Merino, Rosa
Garcia-Consuegra, Julia
JOURNAL OF RHEUMATOLOGY, 2010, 37 (09) : 1970 - 1971
[29] Long Term Safety and Efficacy of Etanercept in Juvenile Idiopathic Arthritis in a Single Center
Bang, Myung Hoon
Kim, Kwang Nam
JOURNAL OF RHEUMATIC DISEASES, 2019, 26 (03): : 200 - 205
[30] Incidence of herpes zoster infections in juvenile idiopathic arthritis patients
S. Nimmrich
G. Horneff
Rheumatology International, 2015, 35 : 465 - 470

← 1 2 3 4 5 →